Shares of Rentokil Initial PLC (NYSE:RTO - Get Free Report) have been assigned an average rating of "Moderate Buy" from the fifteen brokerages that are covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating, eight have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $31.90.
A number of equities research analysts have issued reports on RTO shares. The Goldman Sachs Group raised Rentokil Initial from a "neutral" rating to a "buy" rating in a research report on Monday, July 6th. Investec raised shares of Rentokil Initial to a "buy" rating in a report on Wednesday. Zacks Research lowered shares of Rentokil Initial from a "hold" rating to a "strong sell" rating in a research note on Monday, June 15th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating on shares of Rentokil Initial in a report on Monday, August 3rd. Finally, BNP Paribas Exane downgraded Rentokil Initial from an "outperform" rating to a "neutral" rating and set a $26.70 price target on the stock. in a research report on Friday, July 31st.
Read Our Latest Research Report on Rentokil Initial
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in RTO. Integrated Wealth Concepts LLC bought a new stake in shares of Rentokil Initial in the second quarter valued at about $57,000. NewEdge Advisors LLC increased its stake in Rentokil Initial by 332.7% during the second quarter. NewEdge Advisors LLC now owns 39,213 shares of the company's stock valued at $1,122,000 after acquiring an additional 30,151 shares during the period. Continuum Advisory LLC acquired a new position in Rentokil Initial in the 2nd quarter valued at approximately $42,000. Versant Capital Management Inc raised its holdings in Rentokil Initial by 10.8% in the 2nd quarter. Versant Capital Management Inc now owns 9,965 shares of the company's stock valued at $285,000 after acquiring an additional 970 shares in the last quarter. Finally, Parallel Advisors LLC lifted its position in shares of Rentokil Initial by 50.5% in the 1st quarter. Parallel Advisors LLC now owns 2,107 shares of the company's stock worth $66,000 after acquiring an additional 707 shares during the period. Institutional investors own 9.91% of the company's stock.
Rentokil Initial Stock Performance
Shares of RTO opened at $20.57 on Friday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.07 and a current ratio of 1.16. Rentokil Initial has a 12 month low of $20.52 and a 12 month high of $34.67. The company's fifty day moving average is $24.41 and its 200-day moving average is $28.93.
Rentokil Initial Cuts Dividend
The business also recently disclosed a dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Friday, August 14th were paid a $0.2240 dividend. The ex-dividend date was Friday, August 14th. This is a negative change from Rentokil Initial's previous dividend of $0.4120. This represents a dividend yield of 188.0%.
Rentokil Initial Company Profile
(
Get Free Report)
Rentokil Initial plc is a United Kingdom-based business services company specializing in pest control, hygiene and workplace services. Through its pest control operations, the company provides inspection, prevention and treatment programs for residential, commercial and industrial customers, addressing insects, rodents, birds and other pests.
The company also supplies hygiene and washroom services, including sanitary products, restroom equipment, air-care systems and related maintenance programs.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Rentokil Initial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.
While Rentokil Initial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.